THER-01. PRECLINICAL DEVELOPMENT OF EO1001, A NOVEL IRREVERSIBLE BRAIN PENETRATING PAN-ErbB INHIBITOR

Dysregulation of ErbB-mediated signaling is observed in up to 90% of solid tumors. ErbB family cross-talk is implicated in the development of resistance and metastasis, including CNS metastases. Inhibition of multiple ErbB receptors may result in improved patient outcomes. EO1001 is a novel, patente...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Shen, Wang, Bacha, Jeffrey, Brown, Dennis, Kanekal, Sarath, Sankar, Neil, Wang, ZhenZhong, Pedersen, Harry, Butowski, Nicholas, Nicolaides, Theodore, Sarkaria, Jann, James, C David, Giles, Francis
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213116/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz014.044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados